Exchange: NASDAQ·Updated 04:10 PM EDT

XLO Xilio Therapeutics Inc

$9.02
$0.18
(2.04%)
Today
Closed $9.02
$0.00
(0.00%)
After Hours
Mkt Cap$58.17M
Vol6,570.00

About XLO

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of tumor-activated immuno-oncology therapies for the treatment of cancer. The firm uses its Geographically Precise Solutions (GPS) platform to develop tumor-activated molecules, including cytokines, antibodies and other biologics. The company was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
37

Bearish Sentiment

How do you feel about XLO?

Advertisement|Remove ads.